| Session | Presenter | Title |
|---|---|---|
| Best Clinical Trials |
Patrick Serruys
Japan |
Patients With a Small Annulus in the LANDMARK Trial - Early Outcomes With Three TAVI Valves |
| Best Clinical Trials |
Mi Hee Jang
Korea |
Drug-Coated Balloon-Based Treatment for De Novo Coronary Artery Disease in Patients With High-Bleeding Risk |
| Best Clinical Trials |
Bu-Yuan Hsiao
Taiwan |
Machine Learning Prediction of Post-AMI Outcomes Using Clinical and Pharmacological Variables: A Multi-Hospital Cohort Study |
| Best Clinical Trials |
Sofian Zreigh
Turkey |
Regional Variations in Sex-Based Outcomes of Transcatheter Aortic Valve Replacement: A Meta-Analysis of 657,850 Patients |
| Best Clinical Trials |
Akihiro Tobe
Japan |
Early Outcomes With Three TAVI Valves in Women - Insight of LANDMARK Trial |
| Best Clinical Trials |
Yoshinobu Onuma
Ireland |
Comparative Analysis of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography, Murray Law-Based Quantitative Flow Ratio, and Quantitative Flow Ratio at Sequential Side Branches in Patients With Complex CAD: Insights From the FASTTRACK CABG Study |
|
Moderated Abstract Competition 1
1-1. Coronary Intervention |
Ae-Young Her
Korea |
Drug-Coated Balloon Versus Drug-Eluting Stent Revascularization in the Treatment of De Novo Acute Myocardial Infarction |
|
Moderated Abstract Competition 1
1-2. Imaging & Physiology |
Koshiro Sakai
Japan |
Plaque Distribution in Functional Focal and Diffuse Coronary Artery Disease |
|
Moderated Abstract Competition 1
1-3. Structural Heart Disease |
Huan-Chiu Lin
Taiwan |
Long-Term Clinical Outcomes and Durability of Early-Generation Transcatheter Heart Valves in High-Risk Elderly Patients |
|
Moderated Abstract Competition 1
1-4. Miscellaneous (Others) |
Shuaihua Qiao
China |
Lymph Node Exosomes Delivery Attenuates Myocardial Ischemia-Reperfusion Injury via Regulating PTEN-PI3K/Akt Pathway Mediated Myocardiocyte Apoptosis |
|
Moderated Abstract Competition 1
1-5. Acute Coronary Syndromes |
Kei Tung Wong
Hong Kong, China |
12-Month Clinical Outcomes of ST Segment Elevation Myocardial Infarction Treated With DynamX Bioadaptor During Primary Percutaneous Intervention - A Single Centre Experience |
|
Moderated Abstract Competition 1
1-6. Innovation in Cardiovascular Disease |
Vinayak Nagaraja
USA |
Fully Automated Aortic Root Localization and Tilt Alignment in Cardiac Computed Tomography |
|
Moderated Abstract Competition 1
1-7. CTO |
Cheng-Wei Lien
Taiwan |
Development and Validation of a Global Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The Taiwan Research Initiative on Coronary Total Occlusion (TRIO) Score |
|
Moderated Abstract Competition 1
1-8. Endovascular Intervention |
Sania Zahrani
Indonesia |
Intravascular Ultrasound (IVUS)-Guided Angioplasty for Femoropopliteal Lesions: An Updated Meta-Analysis of Its Efficacy |
|
Moderated Abstract Competition 2
2-1. Coronary Intervention |
Eran Wen Jun Sim
Singapore |
Drug-Coated Balloon Enhanced MOdified JAiled Balloon (DEMOJAB) Technique - A Novel Modification of the Jailed Balloon Technique (A Case Series) |
|
Moderated Abstract Competition 2
2-2. Complex PCI |
Yiting Wu
Taiwan |
Prognostic Value of Neutrophil-Lymphocyte Ratio in Chronic Renal Insufficiency Patients Undergoing Percutaneous Coronary Intervention |
|
Moderated Abstract Competition 2
2-3. Acute Coronary Syndromes |
Chia-Chen Lee
Taiwan |
Personalizing Antiplatelet Therapy in Acute Coronary Syndrome: Clinical Utility of the HANC Score |
|
Moderated Abstract Competition 2
2-4. Complex PCI |
Takahide Murasawa
Japan |
Predictors of Intravascular Lithotripsy Balloon Rupture During Percutaneous Coronary Intervention for Highly Calcified Lesions |
|
Moderated Abstract Competition 2
2-5. Imaging & Physiology |
Juri Iwata
Japan |
Long-Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation |
|
Moderated Abstract Competition 2
2-6. Structural Heart Disease |
Christina Mew
Australia |
Incidence and Temporal Trends in Permanent Pacemaker Implantation (PPI) Following Transcatheter Aortic Valve Replacement (TAVR): A Single Australian Centre Experience |
|
Moderated Abstract Competition 2
2-7. Treatment After Coronary Intervention |
Yu Chen Wang
Taiwan |
The Prasugrel Reduced-Dose Observation for Measuring Improvement in Safety and Effectiveness in Taiwan (PROMISE-TW) Registry |